Skip to main content

Peer Review reports

From: Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis

Original Submission
16 Jul 2021 Submitted Original manuscript
27 Jul 2021 Reviewed Reviewer Report - Hannah K. Drescher
9 Aug 2021 Reviewed Reviewer Report - Michael Estep
10 Sep 2021 Author responded Author comments - Narges Mohammadtaghvaei
15 Sep 2021 Author responded Author comments - Narges Mohammadtaghvaei
Resubmission - Version 2
10 Sep 2021 Submitted Manuscript version 2
Publishing
20 Sep 2021 Editorially accepted
1 Oct 2021 Article published 10.1186/s40360-021-00524-8

You can find further information about peer review here.

Back to article page